Horwitz, Allan V. (Author)
Many of the most common types of mental health problems that are found in outpatient psychiatric and general medical practices are diffuse, undifferentiated, and amorphous. Before the 1970s this lack of specificity did not conflict with the dominant theories and treatments of the American psychiatric profession or the demands of third party insurers and regulators. However, since that time the legitimacy and solvency of the psychiatric profession has come to depend on the perception that it treats specific disease entities. The establishment of the DSM-III in 1980 provided American psychiatry with many standardized disease entities that could be precisely measured, quantified, and abstracted from their particular contexts. In the late 1980s, these entities became the targets of the new class of psychoactive drugs, the Selective Serotonin Reuptake Inhibitors. Professional, political, economic, and cultural forces that arose in a particular historical era account for the standardization of mental illnesses.
...MoreDescription On psychiatric drugs.
Article Pieters, Toine; Snelders, Stephen (2011) Standardizing Psychotropic Drugs and Drug Practices in the Twentieth Century: Paradox of Order and Disorder. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences (p. 412).
Article
Pieters, Toine;
Majerus, Benoît;
(2011)
The Introduction of Chlorpromazine in Belgium and the Netherlands (1951--1968); Tango between Old and New Treatment Features
(/isis/citation/CBB001221534/)
Article
Herzberg, David;
(2011)
Blockbusters and Controlled Substances: Miltown, Quaalude, and Consumer Demand for Drugs in Postwar America
(/isis/citation/CBB001221531/)
Thesis
Hanganu-Bresch, Cristina;
(2008)
Faces of Depression: A Study of Antidepressant Advertisements in the American and British Journals of Psychiatry, 1960--2004
(/isis/citation/CBB001561430/)
Article
Balz, Viola;
Hoheisel, Matthias;
(2011)
East-Side Story: The Standardisation of Psychotropic Drugs at the Charité Psychiatric Clinic, 1955--1970
(/isis/citation/CBB001221535/)
Article
Pieters, Toine;
Snelders, Stephen;
(2011)
Standardizing Psychotropic Drugs and Drug Practices in the Twentieth Century: Paradox of Order and Disorder
(/isis/citation/CBB001221530/)
Book
Ghaemi, S. Nassir;
(2013)
On Depression: Drugs, Diagnosis, and Despair in the Modern World
(/isis/citation/CBB001553380/)
Book
Lane, Christopher;
(2007)
Shyness: How Normal Behavior Became a Sickness
(/isis/citation/CBB001210279/)
Book
Healy, David;
(2004)
Let Them Eat Prozac: The Unhealthy Relationship between the Pharmaceutical Industry and Depression
(/isis/citation/CBB000630180/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms
(/isis/citation/CBB001221032/)
Book
Shorter, Edward;
(2009)
Before Prozac: The Troubled History of Mood Disorders in Psychiatry
(/isis/citation/CBB000952059/)
Article
Abraham, John;
Davis, Courtney;
(2009)
Drug Evaluation and the Permissive Principle: Continuities and Contradictions between Standards and Practices in Antidepressant Regulation
(/isis/citation/CBB000953573/)
Chapter
Hess, Volker;
(2008)
Secrets, Bureaucracy and the Public Drug Regulation in Prussia of the Early 19th Century
(/isis/citation/CBB001221034/)
Article
Daemmrich, Arthur;
Bowden, Mary Ellen;
(2005)
A Rising Drug Industry: Pharmaceuticals since 1870
(/isis/citation/CBB001221029/)
Article
McGoey, Linsey;
(2010)
Profitable Failure: Antidepressant Drugs and the Triumph of Flawed Experiments
(/isis/citation/CBB000953791/)
Chapter
Simon, Jonathan;
(2008)
French Serum Regulation in 1895: The Necessary Minimum or the Maximum Possible?
(/isis/citation/CBB001221038/)
Book
Jonathan Sadowsky;
(2020)
The Empire of Depression: A New History
(/isis/citation/CBB846402776/)
Article
Godderis, Rebecca;
(2013)
A Tricky Object to Classify: Evidence, Postpartum Depression and the DSM-IV
(/isis/citation/CBB001320226/)
Article
Jean-Paul Gaudillière;
Lucie Gerber;
(2016)
Marketing Masked Depression: Physicians, Pharmaceutical Firms, and the Redefinition of Mood Disorders in the 1960s and 1970s
(/isis/citation/CBB665653849/)
Article
Hirshbein, Laura D.;
(2006)
Science, Gender, and the Emergence of Depression in American Psychiatry, 1952--1980
(/isis/citation/CBB000671051/)
Chapter
Daemmrich, A.;
Greene, J.;
(2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
(/isis/citation/CBB001221031/)
Be the first to comment!